Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-28
1989-08-29
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514278, 514382, 5142335, 544 70, 544230, 546 15, 548253, 548309, A61K 31415, C07D491107
Patent
active
048617920
ABSTRACT:
Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group,
REFERENCES:
patent: 4740517 (1988-04-01), Kurono et al.
Kinoshita, J. H. et al., Jap.J.Ophthalmol., vol. 20, 339-410, 1976.
Kenneth H. Gabbay, Int. Congr. Ser. Excerpta Med., vol. 403, p. 594, 1977.
Peterson, M. J. et al., Metabolism, vol. 28, p. 456, 1979.
Ziegler, E., et al., Liebigs Ann. Chem., pp. 1552-1556, 1973.
Witiak, D. T. et al., J. Med. Chem., vol. 14, No. 8, 758-756 (1971).
Asano Kyoichi
Fukushima Masato
Kato Noriaki
Kondo Yasuaki
Kurono Masayasu
Sanwa Kagaku Kenkyusho Co. Ltd.
Schwartz Richard A.
LandOfFree
Hydantoin derivatives for treating complications of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoin derivatives for treating complications of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives for treating complications of diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2238605